LU77666A1 - - Google Patents

Info

Publication number
LU77666A1
LU77666A1 LU77666A LU77666A LU77666A1 LU 77666 A1 LU77666 A1 LU 77666A1 LU 77666 A LU77666 A LU 77666A LU 77666 A LU77666 A LU 77666A LU 77666 A1 LU77666 A1 LU 77666A1
Authority
LU
Luxembourg
Application number
LU77666A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20328354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU77666(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of LU77666A1 publication Critical patent/LU77666A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU77666A 1976-07-01 1977-06-30 LU77666A1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607496A SE7607496L (sv) 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner

Publications (1)

Publication Number Publication Date
LU77666A1 true LU77666A1 (cg-RX-API-DMAC10.html) 1977-10-07

Family

ID=20328354

Family Applications (2)

Application Number Title Priority Date Filing Date
LU77666A LU77666A1 (cg-RX-API-DMAC10.html) 1976-07-01 1977-06-30
LU88310C LU88310I2 (fr) 1976-07-01 1993-06-16 Foscarnet (Foscavir)

Family Applications After (1)

Application Number Title Priority Date Filing Date
LU88310C LU88310I2 (fr) 1976-07-01 1993-06-16 Foscarnet (Foscavir)

Country Status (22)

Country Link
US (4) US4215113A (cg-RX-API-DMAC10.html)
JP (1) JPS536428A (cg-RX-API-DMAC10.html)
AT (1) AT369014B (cg-RX-API-DMAC10.html)
AU (1) AU510809B2 (cg-RX-API-DMAC10.html)
BE (1) BE856355A (cg-RX-API-DMAC10.html)
BG (1) BG60834B2 (cg-RX-API-DMAC10.html)
CA (1) CA1077848A (cg-RX-API-DMAC10.html)
CH (1) CH641471A5 (cg-RX-API-DMAC10.html)
DE (1) DE2728685C2 (cg-RX-API-DMAC10.html)
DK (1) DK288877A (cg-RX-API-DMAC10.html)
FI (1) FI772030A7 (cg-RX-API-DMAC10.html)
FR (1) FR2356424A1 (cg-RX-API-DMAC10.html)
GB (1) GB1585615A (cg-RX-API-DMAC10.html)
HK (1) HK28984A (cg-RX-API-DMAC10.html)
IE (1) IE45753B1 (cg-RX-API-DMAC10.html)
LU (2) LU77666A1 (cg-RX-API-DMAC10.html)
MX (1) MX9203635A (cg-RX-API-DMAC10.html)
MY (1) MY8500125A (cg-RX-API-DMAC10.html)
NL (2) NL180068C (cg-RX-API-DMAC10.html)
NO (1) NO772299L (cg-RX-API-DMAC10.html)
SE (1) SE7607496L (cg-RX-API-DMAC10.html)
SG (1) SG80383G (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003007A3 (en) * 1977-12-22 1979-08-08 Astra Lakemedel Aktiebolag Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK564378A (da) * 1977-12-22 1979-06-23 Astra Laekemedel Ab Fremgangsmaade til fremstilling af amidderivater til bekaempelse af virusinfektioner
DE2926799A1 (de) * 1979-07-03 1981-01-15 Bayer Ag Phosphonoameisensaeurehydrazide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
WO1983002723A1 (en) * 1982-02-12 1983-08-18 Smith, Kendall, O. Anti-viral compositions
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
JPH0761814B2 (ja) * 1984-09-10 1995-07-05 三菱化学株式会社 搬送装置
JPS61217434A (ja) * 1985-03-20 1986-09-27 Mitsubishi Chem Ind Ltd 搬送用装置
JPS6194925A (ja) * 1984-10-12 1986-05-13 Mitsubishi Chem Ind Ltd 搬送用装置
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4880619A (en) * 1985-03-11 1989-11-14 Colgate-Palmolive Company Anticalculus oral composition
US4590064A (en) * 1985-03-11 1986-05-20 Colgate-Palmolive Company Anticalculus oral composition
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
WO1987002246A1 (en) * 1985-10-21 1987-04-23 William Sergio Method for reducing the risk or probability of infection from the aids virus (htlv-iii/lav/arv)
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US6110901A (en) * 1990-07-03 2000-08-29 American Cyanamid Company Method for treating RNA viral infections by using RNA chain terminators
SE9403861D0 (sv) * 1994-11-09 1994-11-09 Astra Ab Novel medicinal use
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
WO1996039148A1 (en) * 1995-06-06 1996-12-12 University Of Southern California Methods and compositions for inhibiting cytomegalovirus replication
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
RU2116790C1 (ru) * 1997-07-02 1998-08-10 Закрытое акционерное общество "Рефарм" Наружное противоинфекционное средство "рефарм"
RU2124881C1 (ru) * 1997-11-26 1999-01-20 Матковская Татьяна Александровна Наружное лечебно-косметическое средство
FI980216A0 (fi) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin foer behandling av vaorfor
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
DE19940748A1 (de) * 1999-08-27 2001-03-01 Hugo Seinfeld Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
US20040131622A1 (en) * 2002-07-15 2004-07-08 Board Of Regents Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids
US7611704B2 (en) * 2002-07-15 2009-11-03 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7455833B2 (en) * 2002-07-15 2008-11-25 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7906115B2 (en) 2002-07-15 2011-03-15 Thorpe Philip E Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7790159B2 (en) * 2002-07-15 2010-09-07 Board Of Regents, The University Of Texas System Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
EP1603542A1 (en) * 2003-03-14 2005-12-14 Epistem Limited Treatment and/or prevention of non-viral epithelial damage
US7424812B2 (en) 2003-05-16 2008-09-16 Stanton Concepts Inc. Multiple function lock
US20090214676A1 (en) * 2005-04-30 2009-08-27 Tissuetech, Inc. Method for treating ocular demodex
US20080045482A1 (en) * 2006-01-27 2008-02-21 Adventrx Pharmaceuticals, Inc. Compositions and methods for the treatment of viral infections
US8128968B2 (en) * 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
WO2009114153A1 (en) * 2008-03-12 2009-09-17 Nektar Therapeutics Oligomer-foscarnet conjugates
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
WO2022153334A1 (en) * 2021-01-15 2022-07-21 Jubilant Generics Ltd Transmucosal dosage forms of foscarnet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
US3836650A (en) * 1971-02-25 1974-09-17 Abbott Lab Method for combating marek's disease in poultry
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003007A3 (en) * 1977-12-22 1979-08-08 Astra Lakemedel Aktiebolag Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections
EP0003275A1 (en) * 1977-12-22 1979-08-08 Astra Läkemedel Aktiebolag Aromatic derivatives of phosphonoformic acid, processes for their preparation, pharmaceutical compositions containing them and their use for combating virus infections
US4372894A (en) 1977-12-22 1983-02-08 Astra Lakemedel Aktiebolag Phosphonoformic acid esters
US4536400A (en) * 1977-12-22 1985-08-20 Astra Lakemedel Aktiebolag Phosphonoformic acid esters

Also Published As

Publication number Publication date
AU2650577A (en) 1979-01-04
AU510809B2 (en) 1980-07-17
GB1585615A (en) 1981-03-11
SE7607496L (sv) 1978-01-02
MY8500125A (en) 1985-12-31
DE2728685A1 (de) 1978-01-12
NL7707235A (nl) 1978-01-03
NO772299L (no) 1978-04-25
US4215113A (en) 1980-07-29
FI772030A7 (cg-RX-API-DMAC10.html) 1978-01-02
NL930053I2 (nl) 1994-01-03
NL930053I1 (nl) 1993-09-01
LU88310I2 (fr) 1994-05-04
US4339445A (en) 1982-07-13
HK28984A (en) 1984-04-06
IE45753L (en) 1978-01-01
SG80383G (en) 1984-08-03
US4665062A (en) 1987-05-12
CH641471A5 (de) 1984-02-29
BE856355A (fr) 1978-01-02
NL180068B (nl) 1986-08-01
CA1077848A (en) 1980-05-20
AT369014B (de) 1982-11-25
DE2728685C2 (de) 1982-09-16
NL180068C (nl) 1987-01-02
DK288877A (da) 1978-01-02
FR2356424A1 (fr) 1978-01-27
FR2356424B1 (cg-RX-API-DMAC10.html) 1980-04-18
US4771041A (en) 1988-09-13
JPS562046B2 (cg-RX-API-DMAC10.html) 1981-01-17
MX9203635A (es) 1992-09-01
IE45753B1 (en) 1982-11-17
JPS536428A (en) 1978-01-20
BG60834B2 (bg) 1996-04-30
ATA465477A (de) 1982-04-15

Similar Documents

Publication Publication Date Title
FR2356424B1 (cg-RX-API-DMAC10.html)
FR2345007B1 (cg-RX-API-DMAC10.html)
JPS5515939Y2 (cg-RX-API-DMAC10.html)
JPS5630693Y2 (cg-RX-API-DMAC10.html)
CS177446B1 (cg-RX-API-DMAC10.html)
JPS52143078U (cg-RX-API-DMAC10.html)
JPS52126516U (cg-RX-API-DMAC10.html)
JPS5389576U (cg-RX-API-DMAC10.html)
JPS5393008U (cg-RX-API-DMAC10.html)
JPS52171778U (cg-RX-API-DMAC10.html)
CS178373B1 (cg-RX-API-DMAC10.html)
JPS5380604U (cg-RX-API-DMAC10.html)
CS177442B1 (cg-RX-API-DMAC10.html)
JPS5391080U (cg-RX-API-DMAC10.html)
CH598142A5 (cg-RX-API-DMAC10.html)
CH611076A5 (cg-RX-API-DMAC10.html)
CH600827A5 (cg-RX-API-DMAC10.html)
DD126330A1 (cg-RX-API-DMAC10.html)
BG23440A1 (cg-RX-API-DMAC10.html)
BG23504A1 (cg-RX-API-DMAC10.html)
DD126090A1 (cg-RX-API-DMAC10.html)
CH602194A5 (cg-RX-API-DMAC10.html)
CH609904A5 (cg-RX-API-DMAC10.html)
DD126207A1 (cg-RX-API-DMAC10.html)
CH614785A5 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
DT Application date
TA Annual fee